nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial

nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial

Josep Tabernero,1 Volker Kunzmann,2 Werner Scheithauer,3 Michele Reni,4 Jack Shiansong Li,5 Stefano Ferrara,6 Kamel Djazouli7 1Medical Oncology Department, Vall d’Hebron University Hospital, Barcelona, Spain; 2Medizinische Klinik und Poliklinik II, University of Würzburg, W&u...

Full description

Bibliographic Details
Main Authors: Tabernero J, Kunzmann V, Scheithauer W, Reni M, Shiansong Li J, Ferrara S, Djazouli K
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:OncoTargets and Therapy
Subjects:
metastatic pancreatic cancer
nab-paclitaxel
gemcitabine
Western Europe
MPACT
Online Access:https://www.dovepress.com/nab-paclitaxel-plus-gemcitabine-for-metastatic-pancreatic-cancer-a-sub-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/nab-paclitaxel-plus-gemcitabine-for-metastatic-pancreatic-cancer-a-sub-peer-reviewed-article-OTT

Similar Items